InvestorsHub Logo
Followers 9
Posts 3106
Boards Moderated 0
Alias Born 11/17/2021

Re: None

Wednesday, 10/05/2022 2:03:14 PM

Wednesday, October 05, 2022 2:03:14 PM

Post# of 91832
$LUDG - Ludwig Enterprises announced more detail on their Genomic-Based mRNA Inflammatory Index - A Ground-Breaking Technology, cooperative contracts, and current applications.

This technology's potential medical and commercial value is revealed in a Research and Markets via Business Wire titled: "Global Biochips Market Report 2022: Increasing Adoption of Personalized Medicine Drives Growth." "The rising prevalence of chronic diseases, such as cancer and diabetes, has increased demand for early diagnosis. In addition, the increasing adoption of personalized medicine and point-of-care (POC) testing is estimated to propel market growth." "Global biochip market expected to reach USD 34.35 billion in 2030."

This is a major catalyst for growth for $LUDG!

https://finance.yahoo.com/news/ludwig-genomic-based-mrna-inflammatory-130000616.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.